Skip to main content

Visual Function

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Alcon
AlconFORT WORTH, TX
1 program
1
AcrySof® Toric IOLPhase 41 trial
Active Trials
NCT00758550Completed60
Lighthouse Pharmaceuticals
Lighthouse PharmaceuticalsCA - San Francisco
1 program
Izon Wavefront-guided lensesN/A1 trial
Active Trials
NCT00894192Unknown300Est. Dec 2009

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AlconAcrySof® Toric IOL
Lighthouse PharmaceuticalsIzon Wavefront-guided lenses

Clinical Trials (2)

Total enrollment: 360 patients across 2 trials

NCT00758550AlconAcrySof® Toric IOL

Visual Function After Bilateral Implantation of AcrySof® Toric

Start: Apr 200760 patients
Phase 4Completed
NCT00894192Lighthouse PharmaceuticalsIzon Wavefront-guided lenses

Comprehensive Evaluation of Visual Function

Start: Feb 2009Est. completion: Dec 2009300 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.